(
100
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
Website
Collapse
-
5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
-
5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
-
A comparative dose-response study of prophylactic peanut allergy SLIT and EPIT in Brown Norway rats
-
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
-
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
-
Absence of alpha-tryptase isoforms is associated with less severe allergic reactions at food challenge to peanut
-
Achieving Remission with Peanut Sublingual Immunotherapy
-
Alcohol consumption can impair intestinal barrier integrity and increases the transport of peanut allergens through the epithelium
-
Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years
-
Allergic Phenotype Differences Between Peanut and Tree Nut Allergic Individuals
-
Audit of Peanut Allergy Patients Eligible for Oral Immunotherapy (OIT) in a Paediatric Cohort at Galway University Hospital (2020-2023)
-
Analytical Performance Evaluation of Peanut Components on IMMULITE 2000 XPi Platform
-
Assessing the role of specific IgA in prophylactic sublingual immunotherapy for peanut allergy: A Brown Norway rat study
-
Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy
-
Basophil activation test has high accuracy to diagnose peanut and cashew allergies in Australian children
-
Characterization on genome-wide profile of H3K4me2 histone methylation in mouse skin suffering from peanut allergic sensitization
-
Cowpea, pea, and peanut – what´s the link?
-
Daily life with a peanut allergy, as a young adult- an interview study
-
Desensitization with the potential for remission with peanut SLIT
-
Development of a preclinical murine model for peanut protein allergy
-
Development, characterization and application of aptamers for the detection and quantification of the major peanut allergen Ara h 1
-
Diagnostic accuracy of the Hoxb8 MAT for peanut allergy
-
Dietary feasibility and adherence to an immune supportive diet in children with a peanut or nut allergy; results from a subpopulation of the randomized controlled clinical DIAMETER study
-
Early intervention for peanut allergy: Is there a window of opportunity?
-
Epicutaneous Immunotherapy with Peanut Allergy
-
Evaluation of ancient legume proteins cross-recognition by IgEs from patients allergic to peanut and other legumes
-
Fecal IgE in Peanut Allergy: Pioneering Evidence and Clinical Implications
-
Fecal IgE in Peanut Allergy: Pioneering Evidence and Clinical Implications
-
Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure
-
Health-Related Quality of Life in Children and Adults with Peanut and Tree Nut Allergies Data from the TINA Study
-
High degree of desensitization after one year of early-life peanut oral immunotherapy – SmaChO Randomized Controlled Trial
-
High degree of sustained unresponsiveness and safety after three years of slow up-dose peanut oral immunotherapy in toddlers – results from the SmaChO study (Small Children Oral Immunotherapy)
-
IgE-sensitisation profile to peanut allergen components: reassessment of the prevalence and patterns on a global scale
-
IgG-mediated anaphylaxis in a mouse model of peanut allergy
-
Immunotherapy-induced neutralising antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
-
Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
-
Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats
-
Impact of participant baseline factors on exposure-adjusted incidence of treatment-related adverse events during peanut oral immunotherapy
-
Improved In-vitro Allergy Diagnostics using a Molecular Composite of Purified Peanut Allergens
-
Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years
-
Infant feeding and allergy prevention guidelines reduce IgE-mediated egg and peanut allergies prevalence – a cohort comparison study
-
Introducing tree nuts to peanut allergic patients: it’s not peanuts at all!
-
Is Peanut Allergy prevalence increasing in Portugal? Evidence from the last decade at a Portuguese tertiary care hospital
-
Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial
-
MY006: A Trispecific Antibody Blocking Four Allergenic Epitopes For the Treatment of Peanut Allergy
-
MY006: anti-allergen multispecific antibody for the treatment of peanut allergy
-
Mannan-allergoids for food allergies: Production and characterization of peanut extracts treated with glutaraldehyde
-
Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model
-
Oral and skin sensitisation to peanut induce distinct immune response profiles – identification of potential biomarkers of route of sensitisation?
-
Peanut Allergy Sensitization Profile in Vallès Occidental (Barcelona): A 2023 Cohort Study
-
Peanut allergens differently adhere to oral epithelia
-
Peanut allergy diagnosis. Our experience
-
Peanut and tree nut allergen components around the corner – for potential future use in the clinic?
-
Peanut and tree nut allergy screening by Basophil Activation Testing
-
Peanut and tree nut allergy screening by Basophil Activation Testing
-
Peanut oral immunotherapy has not recuded basophil activation
-
Peanut oral immunotherapy in toddlers
-
Peanut-specific IgG subclasses as biomarkers of peanut allergy
-
Preliminary results of first-in-human dose escalation of VLP Peanut in healthy subjects
-
Protein Kinetics in Peanut Allergy: Insights from an Inflammation Panel Analysis of Cell Culture Supernatants
-
Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy
-
Quantifying allergenic versus non-allergenic peanut proteins by mass spectrometry
-
Reevaluating the use of peanut storage proteins for diagnostic purposes
-
Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics of IGNX001 in Peanut-Allergic (PA) Adults and Older Adolescents – Day 8 Safety Data for Cohort 1 of the ACCELERATE Peanut Study
-
Specific IgE and IgG4 changes in adults undergoing peanut immunotherapy combined with omalizumab
-
Staggered oral peanut challenge with regular consumption at home
-
Stallergenes : Navigating the complexities of peanut allergy in toddlers
-
Storage proteins: clinical and molecular patterns of peanut and tree nut allergy of a pediatric portuguese population
-
Structural analysis of IgE epitopes of Ara h 2 reveals simultaneous binding of three copies of a human derived IgE Fab fragment to the major peanut allergen
-
Structural analysis of IgE epitopes on major peanut allergens Ara h 2 and Ara h 6
-
Subcutaneous administration of a novel Virus-like Particle Vaccine for the Treatment of Peanut Allergy is safe and well tolerated
-
Sublingual immunotherapy with peanut protein extract has an effect in Brown Norway rats sensitised via the skin
-
Successful translation of the ex vivo immunomodulatory pharmacodynamic profile of VLP Peanut to the clinic
-
The Hoxb8 mast cell activation test features high diagnostic accuracy for peanut allergy
-
The epicutaneous immunotherapy for peanut allergy: most recent results and perspectives
-
The importance of the storage proteins for allergenicity and molecular patterns of cross-reactvity in a peanut and tree nut allergic pediatric population
-
The peanut-specific antibody profile during three different mucosal immunotherapies for peanut allergy in Brown Norway rats
-
Towards risk assessment of peanut sensitised patients based on statistical modelling of 32,500 IgE-macroarray test results
-
What is the optimal time for diagnosis and treatment of peanut allergy in children?
-
Allergenic properties of various peanut extracts prepared using commercial peanut flours
-
Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years
-
Basophil Activation by Digested Peanut Protein Enhances the Prediction of Clinical Reactivity and Delayed Responses in Peanut Allergy
-
Boiled peanut or roasted peanut for oral immunotherapy: Results from the BOPI-2 Study
-
Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)
-
Modified Peanut Allergen mRNA: A Novel Vaccine for Peanut Allergy
-
Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy
-
Patient-reported outcomes after 5 years of oral immunotherapy for peanut allergy: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
-
Patterns of peanut ingestion in remission vs desensitized patients after completion of peanut oral immunotherapy at 3-years post-treatment
-
Peanut Lectin: Why It Is Not a Major Peanut Allergen
-
Peanut allergen-loaded microneedle array patch modulates the immune response to peanut allergy in Balb/c and C3H/HeJ mouse model
-
Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers
-
The impact of peanut allergy on health care resource utilization (HCRU) in Europe: A cross-sectional study to assess HCRU in children with peanut allergy compared to children with no food allergy
-
Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model
Show more Sessions (91)Show Less-
